DeepMind spinout Isomorphic Labs partners with Eli Lilly and Novartis on AI-based drug discovery, with $82.5M paid upfront and $2.9B in performance incentives
TechCrunch Kyle Wiggers
Related Coverage
- Alphabet's AI-driven drug discovery startup Isomorphic lands $3 billion pharma deals with Lilly and Novartis TechStartups
- Google Deepmind shows that AI in medicine could be more lucrative than just the next LLM The Decoder
- Alphabet's Isomorphic Labs Partners Lilly and Novartis for AI-driven Drug Discovery Metaverse Post
- Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery Benzinga
- Isomorphic signs drug discovery deals with Eli Lilly and Novartis Silicon Republic
- Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations Isomorphic Labs
- Isomorphic Labs Signs Lucrative Drug Discovery Deals with Eli Lilly and Novartis Cryptopolitan
- AI drug discovery startup Isomorphic Labs partners with Eli Lilly and Novartis SiliconANGLE
- OpenAI is Slowly Turning into a Healthcare Company Analytics India Magazine
- Isomorphic Labs Signs Deal Valued Up To $1.7 Billion With Eli Lilly Pulse 2.0
- Alphabet's Isomorphic Labs In Drug Discovery Deals With Eli Lilly, Novartis Investor's Business Daily
- Alphabet's Isomorphic Labs to Collaborate With Novartis, Lilly Bloomberg
- Strategic Multi-target Research Collaboration with Novartis Isomorphic Labs
- Isomorphic Labs Announces Strategic Multi-target Research Collaboration with Lilly Isomorphic Labs
Discussion
-
@garymarcus
Gary Marcus
on x
In the race between DeepMind and OpenAI my bet is still on Demis.
-
@sergeiiakhnin
Sergei Yakneen
on x
Newsflash! We are now partnered with @EliLillyandCo & @Novartis in deals worth up to nearly $3 billion to develop new medicines against challenging targets. This is showtime for the AI tech we've been building for the last two years. Let's go! http://www.isomorphiclabs.com/ ... #…
-
@andrewe_dunn
Andrew Dunn
on x
“They're not pilot projects. They're real drug targets,” @demishassabis told me. “We want to do things that ultimately, if successful, are really meaningful, actually cure diseases and lead to blockbuster drugs, rather than just pilots and sort of academic work.”
-
@isomorphiclabs
@isomorphiclabs
on x
We are thrilled to announce our pharma collaborations with @EliLillyandCo & @Novartis, which combined are potentially worth nearly $3 billion and testament to the promise of our AI-first approach to drug design. Read more here: http://www.isomorphiclabs.com/ ... #AI #drugdiscover…
-
@demishassabis
Demis Hassabis
on x
Thrilled to announce @IsomorphicLabs collaborations with @EliLillyandCo & @Novartis potentially worth nearly $3 billion. These target-based programs represent just the start of the phenomenal real-world impact AI will have in accelerating drug discovery: http://www.isomorphiclabs…